Biologica Technologies Presents Update on ProteiOS Growth Factor

Biologica Technologies is debuting initial clinical data from spinal applications using its ProteiOS® growth factor derived from minimally manipulated allogeneic bone marrow. ProteiOS comprises angiogenic, mitogenic and osteoinductive proteins and what is reportedly the highest amount of non-recombinant BMP-2, and is designed for use with a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us